Clinical Trial Update: Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating gemcitabine as part of chemoradiotherapy for locally advanced cervical cancer in patients with renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Cervical Cancer | Phase 2 | Status: RECRUITING